Educate. Innovate. Serve.| neurology.duke.edu
The Duke Center for Neurodegeneration and Neurotherapeutics (DCNN) is made of an interdisciplinary team of experts from across Duke that works to advance our understanding of neurodegenerative disease, with the expectation that such advances will offer opportunities for leveraging acquired mechanistic knowledge into substantive opportunities for therapy development. Read more about the DCNN and its work here.| neurology.duke.edu
The Sanders Lab studies Parkinson’s disease (PD), the most common neurodegenerative movement disorder. Even with expert treatment, PD patients typically deteriorate over time and endure considerable motor and non-motor disability. There are no disease modifying therapies, thus, this is an urgent unmet medical need. We take a translational approach (i.e. bench-to-bedside), aiming to translate our multidisciplinary basic scientific research into meaningful health outcomes for PD patients. To ...| neurology.duke.edu
December 6, 2023 | By William Alexander Originally published by Duke School of Medicine --- Sharon Fekrat, MD, FASRS, sees the retina, the lining of the eye that translates visual signals from the eye into what the brain perceives as sight, as both a thing of beauty and a| News RSS Feed
Junjie Yao, PhD, grew up dreaming about the potential health applications of combining engineering and biology. Yao pursued this passion through his graduate studies and then joined the biomedical engineering program at Duke, where he studied an emerging imaging technology known as photoacoustic tomography (PAT).| Duke Department of Neurology
